| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/18/2005 | CN1615834A Non injection medicament containing new sodium houttuyfonate |
| 05/18/2005 | CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/18/2005 | CN1615832A Ritodrine hydrochloride powder injection and preparing method |
| 05/18/2005 | CN1615831A Pseudoephedrine hydrochloride dripping pill |
| 05/18/2005 | CN1615830A Amfepramone hydro chloride dripping pill |
| 05/18/2005 | CN1615829A Use of sinapine in preparing medicine for preventing and curing senile dementia |
| 05/18/2005 | CN1615828A Garlicin injection emulsion and its preparing method |
| 05/18/2005 | CN1615827A Medicinal powder injection for respiratory system and preparing method |
| 05/18/2005 | CN1615826A Guaiamar dripping pill |
| 05/18/2005 | CN1615825A Poly unit slow release preparation |
| 05/18/2005 | CN1615822A Fat milk transfusion fluid for treating pulmonary heart disease and energy supplement and its producing method |
| 05/18/2005 | CN1615821A Embolism agent |
| 05/18/2005 | CN1202137C Chitosam chromium, its preparing method and application |
| 05/18/2005 | CN1202135C Chi Iucid ganoderma polysaccharide and prep. and use thereof |
| 05/18/2005 | CN1202134C Polysaccharide compound having immune stimulating activity |
| 05/18/2005 | CN1202123C Crystalline forms of IS-[la(pha(2S, 3R),9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl) carbonyl]-amino] actahydro-6H-piridazino [1,2-A] [1,2] diazepin-1-carboxamide |
| 05/18/2005 | CN1202120C Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain |
| 05/18/2005 | CN1202119C Hemsleyadine derivative and its preparing method and use as bactericidal agent |
| 05/18/2005 | CN1202118C Adenosine derivatives |
| 05/18/2005 | CN1202116C Avermectin derivatives |
| 05/18/2005 | CN1202108C Spiro compounds, preparing method and intermediate |
| 05/18/2005 | CN1202104C 2-phenylpyran-4-one derivatives |
| 05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
| 05/18/2005 | CN1202096C 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1202087C Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 05/18/2005 | CN1202081C Amidino and guanidino bita-azetidinone tryptase inhibitors |
| 05/18/2005 | CN1202078C Method of producing n-(4,5-bis-(methanesulfonyl)-2-methyl-benzoyl)-guanidine, hydrochloride and its preparing method |
| 05/18/2005 | CN1202069C Use of diterpenvid monomer compound in preparing anti-cancer drugs |
| 05/18/2005 | CN1202068C Aspirin-triggered lipid mediators |
| 05/18/2005 | CN1202067C Method for preparing medicinal grade ferric citrate |
| 05/18/2005 | CN1201822C Compositions comprising sympathomimetic amine salts unsuitable for illegal use |
| 05/18/2005 | CN1201821C Stable complex of insoluble chemical compound |
| 05/18/2005 | CN1201820C Compositions containing benzimidazolones and progestogens |
| 05/18/2005 | CN1201814C Treatment of cardiao megaly |
| 05/18/2005 | CN1201791C External plaster for treating rheumatic arthralgia and its preparing method |
| 05/18/2005 | CN1201771C Burn paste and its preparing method |
| 05/18/2005 | CN1201766C External use plaster for curing cervical spondylopathy |
| 05/18/2005 | CN1201762C A medicine for treating scald and burn, and method for preparing same |
| 05/18/2005 | CN1201760C Soft capsule for treating coronary disease and stenocardia and process for preparing same |
| 05/18/2005 | CN1201750C Oculentum for treating eye disease and preparing method thereof |
| 05/18/2005 | CN1201749C Vaginal delivery of bisphosphonates |
| 05/18/2005 | CN1201748C Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 05/18/2005 | CN1201747C External applied medicine composition containing vitamin B |
| 05/18/2005 | CN1201746C Erigeron breviscapus liposome and its freeze dried powder injection and preparation method |
| 05/18/2005 | CN1201745C Medicine composition contg. effective part of astragalus root |
| 05/18/2005 | CN1201744C Rinsing liquid for treating endometritis and its preparation method |
| 05/18/2005 | CN1201743C Composition of gensenoside Rg1 and ferulic acid for preventing and treating cardiac and cerebral vascular diseases and diabetes and its application |
| 05/18/2005 | CN1201742C Hypoglycemic health-care food for diabetes type II |
| 05/18/2005 | CN1201741C Preventives and remedies for ischemic reflow disorder |
| 05/18/2005 | CN1201740C Intermittent claudication therapeutic drugs comprising phyrroloazepines |
| 05/18/2005 | CN1201739C Slow-release medicine system of compound rifampicin |
| 05/18/2005 | CN1201738C Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 05/18/2005 | CN1201737C Application of cepharanthine in preparing medicine for resisting SARS virus |
| 05/18/2005 | CN1201736C Slow-releasing metronidazole prepn for position of colon |
| 05/18/2005 | CN1201735C Mycobacterial inhibitors |
| 05/18/2005 | CN1201734C Use of sulfocanbamide derivative in preparation of medicine treating eye yellow spot variation |
| 05/18/2005 | CN1201733C Omega-3 fatty acid capsule |
| 05/18/2005 | CN1201732C Oral pharmaceutical forms of administration with a delayed action |
| 05/18/2005 | CN1201731C Medicine preparation and its use and the use of high grade primary alcohol mixture |
| 05/18/2005 | CN1201730C Treatment of emphysema using RAR selective retinoid agonists |
| 05/18/2005 | CN1201723C Skin and tissue care and/or treatment agent and its use |
| 05/17/2005 | US6894188 Adrenergic nblocking agent; benign prostatic hyperplasma |
| 05/17/2005 | US6894185 Substituted chiral allosteric hemoglobin modifiers |
| 05/17/2005 | US6894184 Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides |
| 05/17/2005 | US6894177 Viricides; human immunodeficiency virus |
| 05/17/2005 | US6894171 Protease inhibitors; viricides; purity, crystal structure |
| 05/17/2005 | US6894168 Carbamoyl tetrahydropyridine derivatives |
| 05/17/2005 | US6894167 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
| 05/17/2005 | US6894166 Dichlorinated heterocyclic compounds and methods of synthesis |
| 05/17/2005 | US6894165 Imidazonaphthyridines |
| 05/17/2005 | US6894162 Intermediates in cephalosporin production |
| 05/17/2005 | US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 05/17/2005 | US6894136 Mold inhibitor integrated within a matrix and method of making same |
| 05/17/2005 | US6894079 Method for reducing free-radical induced injury |
| 05/17/2005 | US6894078 Alcohol based topical anesthetic formulation and method |
| 05/17/2005 | US6894077 Preventive or remedy for hypertension |
| 05/17/2005 | US6894076 Analgesics |
| 05/17/2005 | US6894075 4′-demethyl-4′-O-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same |
| 05/17/2005 | US6894073 Use of diterpene compound as a therapeutic agent of inflammation, immune disease or cancer |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894071 Medical compositions for intravesical treatment of bladder cancer |
| 05/17/2005 | US6894069 Antihypoxic agent, antiischemic agents; anticonvulsants; respiratory system disorders for infants; administering 2-iminobiotin as nitric oxide synthase inhibitor |
| 05/17/2005 | US6894068 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |
| 05/17/2005 | US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases |
| 05/17/2005 | US6894064 Benzothiophenes, formulations containing same, and methods |
| 05/17/2005 | US6894062 Modulation circadian rhythm disorders |
| 05/17/2005 | US6894060 Method for the treatment of dermal lesions caused by envenomation |
| 05/17/2005 | US6894058 Administering statin drug |
| 05/17/2005 | US6894056 Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome |
| 05/17/2005 | US6894054 Central nervous system disorders; muscular disorders |
| 05/17/2005 | US6894052 Serotonergic receptor antagonist |
| 05/17/2005 | US6894051 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 05/17/2005 | US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives |
| 05/17/2005 | US6894049 Anticancer agents; water solubility |
| 05/17/2005 | US6894047 Triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 05/17/2005 | US6894046 For treating eosinophil-dependent inflammatory diseases, asthma |
| 05/17/2005 | US6894044 Treatment of depression, anxiety, psychosis, obesity, pain, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, movement disorders, respiratory diseases, inflammatory diseases, neuropathy, immune disorders, etc. |
| 05/17/2005 | US6894043 Benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |